Retrospective study finds incidental constitutional chromosomal abnormalities in 29,733 bone marrow analyses, highlighting risks of misclassifying cancer prognosis.
Background: Constitutional chromosomal abnormalities detected during bone marrow (BM) chromosome analysis may be misclassified as acquired abnormalities. Although incidental findings identified through somatic tissue testing are increasingly recognized, data on incidental constitutional chromosomal abnormalities remain limited. Methods: We retrospectively reviewed BM chromosome studies performed during 1999-2025 at Asan Medical Center, encompassing 29,733 individuals. Chromosomal abnormalities reported as constitutional, based on germline confirmation or BM cytogenetic findings strongly suggesting a constitutional origin, were included. Cases without clinical recognition were classified as incidental. The cytogenetic spectrum, age at detection, prognostic impact, and follow-up testing were analyzed. Results: <0.001). Family testing was infrequently performed, occurring in five of 15 germline-confirmed cases (33.3%), all of whom were pediatric patients. In hematologic malignancies, inclusion of incidental constitutional abnormalities altered cytogenetic risk classification in five cases. Conclusions: Although incidental constitutional chromosomal abnormalities are rare, these abnormalities can influence prognostic assessment and downstream clinical management. Therefore, accurate recognition and appropriate confirmation are essential for optimal interpretation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: